Latest News

Phase I clinical trials approved by regulators


Phase I clinical trials of cancer drug ETS2101 approved by regulators; the full press release can be read here.

 
-
The Network Pharmacology Company
e-Therapeutics is a drug discovery and development company based in Oxford and Newcastle, UK. The Company is a pioneer of network pharmacology, a distinctive new approach to the discovery of medicines.  

It has a clinical pipeline of four drugs set to enter clinical trials during 2012. The Company is listed on AIM with the ticker symbol ETX.
 
David Cameron at eTherapeutics
British Prime Minister David Cameron and Prof. Malcolm Young, CEO of e-Therapeutics, shake hands as the Prime Minister opens our drug discovery centre at Oxford. more
Webcast

Latest webcast (slides and audio from BIO-CEO, February 2012)

 
Latest corporate presentation
Latest corporate presentation PDF
 
Raj Chopra joins e-Therapeutics’ Board

Raj Chopra joins e-Therapeutics’ Board